Correlation Between Fortress Biotech and Athira Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Athira Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Athira Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Athira Pharma, you can compare the effects of market volatilities on Fortress Biotech and Athira Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Athira Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Athira Pharma.

Diversification Opportunities for Fortress Biotech and Athira Pharma

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fortress and Athira is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Athira Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Athira Pharma and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Athira Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Athira Pharma has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Athira Pharma go up and down completely randomly.

Pair Corralation between Fortress Biotech and Athira Pharma

Given the investment horizon of 90 days Fortress Biotech is expected to generate 0.93 times more return on investment than Athira Pharma. However, Fortress Biotech is 1.07 times less risky than Athira Pharma. It trades about 0.0 of its potential returns per unit of risk. Athira Pharma is currently generating about -0.01 per unit of risk. If you would invest  190.00  in Fortress Biotech on November 1, 2024 and sell it today you would lose (12.00) from holding Fortress Biotech or give up 6.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fortress Biotech  vs.  Athira Pharma

 Performance 
       Timeline  
Fortress Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Fortress Biotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Athira Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Athira Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, Athira Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fortress Biotech and Athira Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fortress Biotech and Athira Pharma

The main advantage of trading using opposite Fortress Biotech and Athira Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Athira Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Athira Pharma will offset losses from the drop in Athira Pharma's long position.
The idea behind Fortress Biotech and Athira Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine